Cisen Pharmaceutical Co., Ltd. (SHA:603367)

Market Cap	6.71B +6.9%
Revenue (ttm)	3.37B -10.1%
Net Income	408.45M -16.6%
EPS	0.90 -16.6%
Shares Out	452.75M
PE Ratio	16.44
Forward PE	n/a
Dividend	0.41 (2.76%)
Ex-Dividend Date	Oct 13, 2025

Volume	3,216,884
Average Volume	6,177,475
Open	14.75
Previous Close	14.81
Day's Range	14.51 - 14.80
52-Week Range	13.43 - 35.20
Beta	0.33
RSI	34.60
Earnings Date	Aug 25, 2026

About Cisen Pharmaceutical

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was former...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1970
• Employees: 3,114
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603367

Financial Performance

In 2025, Cisen Pharmaceutical's revenue was 3.44 billion, a decrease of -13.48% compared to the previous year's 3.98 billion. Earnings were 421.25 million, a decrease of -17.22%.